by 
The Vitreous Tamponades Market is estimated to be valued at US$ 76.0 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Vitreous tamponades are foreign substances utilized to displace the vitreous gel and maintain intraocular pressure after vitreous surgery or retinal detachment surgery. Silicone oil and long chain perfluorocarbon liquids are commonly used vitreous tamponades. Silicone oil, due to its inertness, is widely preferred for vitreous tamponades. It allows examination of the fundus and does not expand at room temperature.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/vitreous-tamponades-market-1193
Market Dynamics:
The growing prevalence of diabetes and increasing number of retinal detachment surgeries are major factors driving growth of the global vitreous tamponades market. Diabetes is a leading cause of blindness globally and vitreous tamponades are commonly used after vitrectomy for treating various diabetic retinopathy conditions. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021 worldwide. Furthermore, silicone oil is increasingly being adopted as vitreous tamponade due to its benefits over long chain perfluorocarbon liquids, which is another factor fueling market growth. However, challenges associated with silicone oil such as emulsification and requirement of secondary surgery for its removal are factors that may hinder market growth over the forecast period.
Segment Analysis
The vitreous tamponades market can be segmented based on type which includes gases, silicone oil and perfluorcarbon liquids. Perfluorcarbon liquids dominate the market currently, accounting for nearly 35% share due to their safety profile and longer duration of action inside the eye.
PEST Analysis
Political: The regulations around product approvals and quality standards set by regulatory bodies like FDA influence new product launches.
Economic: Increased healthcare spending in developing nations and growing prevalence of retinal detachment & macular hole diseases are driving market growth.
Social: Rising awareness about benefits of vitrectomy surgeries and availability of advanced treatments are supporting the market expansion.
Technological: Continuous R&D in developing less invasive tamponades with improved biocompatibility and safety is a key trend.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth, exhibiting a CAGR of 2.5% over the forecast period, due to increasing incidences of retinal detachment and diabetic retinopathy across the world.
Regional analysis: North America dominates the global vitreous tamponades market currently, owing to the developed healthcare infrastructure and increasing number of vitrectomy procedures being performed in the region. Asia Pacific is projected to witness the fastest growth during the analysis period supported by rising medical tourism, healthcare spending and growing ophthalmic disorders.
Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Key players are focusing on new product innovations to consolidate their market share through launch of tamponades with lower viscosity and faster absorption rate inside the eye.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
